We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+4.57%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.79B
AUM Growth
-$730M
Cap. Flow
-$661M
Cap. Flow %
-23.73%
Top 10 Hldgs %
39.61%
Holding
2,225
New
423
Increased
362
Reduced
424
Closed
673
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INDT
476
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$817K 0.03%
15,607
-5,390
-26% -$326K
NTRA icon
477
Natera
NTRA
$45.8B
$806K 0.03%
+18,394
New +$876K
WAT icon
478
Waters Corp
WAT
$40.6B
$803K 0.03%
2,981
-3,730
-56% -$1.19M
IRTC icon
479
iRhythm Holdings
IRTC
$4.05B
$801K 0.03%
6,397
-229
-3% -$33.1K
EXTN
480
DELISTED
Exterran Corporation
EXTN
$798K 0.03%
191,851
+169,481
+758% +$734K
WLK icon
481
Westlake Corp
WLK
$10.3B
$796K 0.03%
+9,159
New +$878K
ALC icon
482
Alcon
ALC
$36.7B
$793K 0.03%
13,626
-3,436
-20% -$238K
GH icon
483
Guardant Health
GH
$22.5B
$792K 0.03%
14,706
-1,237
-8% -$63.5K
NDSN icon
484
Nordson
NDSN
$17.4B
$792K 0.03%
+3,733
New +$836K
TW icon
485
Tradeweb Markets
TW
$22B
$791K 0.03%
14,018
+6,359
+83% +$433K
CLH icon
486
Clean Harbors
CLH
$16.5B
$788K 0.03%
+7,164
New +$767K
KMI icon
487
Kinder Morgan
KMI
$70.4B
$788K 0.03%
47,345
+22,209
+88% +$395K
OC icon
488
Owens Corning
OC
$12.6B
$786K 0.03%
10,003
-8,454
-46% -$710K
RDY icon
489
Dr. Reddy's Laboratories
RDY
$10.4B
$785K 0.03%
75,000
+18,320
+32% +$195K
GGMC
490
DELISTED
Glenfarne Merger Corp. Class A Common Stock
GGMC
$785K 0.03%
79,998
OXY icon
491
Occidental Petroleum
OXY
$59.3B
$784K 0.03%
+12,763
New +$817K
CZR icon
492
Caesars Entertainment
CZR
$6.09B
$783K 0.03%
24,270
-4,775
-16% -$208K
VTI icon
493
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
$779K 0.03%
+4,340
New +$865K
ATCO
494
DELISTED
Atlas Corp.
ATCO
$776K 0.03%
+55,855
New +$727K
DEVS
495
DELISTED
DevvStream Corp
DEVS
$772K 0.03%
7,703
APLS
496
DELISTED
Apellis Pharmaceuticals
APLS
$771K 0.03%
+11,293
New +$668K
AXP icon
497
American Express
AXP
$231B
$770K 0.03%
5,711
+3,558
+165% +$539K
BNY
498
Bank of New York Mellon
BNY
$109B
$769K 0.03%
+19,968
New +$851K
PCT icon
499
PureCycle Technologies
PCT
$1.45B
$767K 0.03%
95,086
-28,001
-23% -$239K
SOC icon
500
Sable Offshore Corp
SOC
$815M
$767K 0.03%
78,005
-140
-0.2% -$1.38K

Similar funds

Prelude Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Prelude Capital Management held 2,225 positions worth $2.79B, down 21% from $3.52B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Prelude Capital Management withdrew a net $661M in Q3 2022, closing 673 positions and reducing 424 holdings. Its most notable exit was KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant, an estimated $43.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Prelude Capital Management opened a new position in KKR Acquisition Holdings I Corp. worth $30.7M.

  • Prelude Capital Management's largest Q3 2022 buy was KKR Acquisition Holdings I Corp.: 3,123,025 shares worth $30.7M.
  • Prelude Capital Management added most to Twitter, Inc. in Q3 2022, an estimated $23.5M increase.
  • Prelude Capital Management's biggest Q3 2022 reduction was Lockheed Martin, cutting an estimated $83M.
  • Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant in Q3 2022, selling an estimated $43.2M.
  • Prelude Capital Management's ten largest holdings make up 40% of its $2.79B portfolio in Q3 2022.
  • Prelude Capital Management opened 423 new positions and closed 673 in Q3 2022.
  • Prelude Capital Management's portfolio value fell 21% quarter-over-quarter to $2.79B.

Based on Prelude Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.